DFTXDefinium Therapeutics Inc. Common Shares
44.91USD-1.99%Mkt Cap: 6.03B $P/E: —3d ago
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap6.03B $
Enterprise Value5.05B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-183.79M $
Revenue/Share—
Last Price44.91 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees105
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-24.21
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B6.64
EPS (TTM)-3.40
EPS (Forward)-1.88
52W Range
8.70088% of range49.70
52W High49.70 USD
52W Low8.700 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-55.30%
ROA-41.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-131.56M $
CapEx (TTM)—
FCF Margin—
FCF Yield0.13%
Net Debt-1.05B $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.12
Current Ratio6.95
Quick Ratio6.89
Book Value/Sh6.837 USD
Cash/Share8.067 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateAug 29, 2022
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)67.47 USD
Upside (mean)+50.2%
Target Range52.00 USD – 90.00 USD
$52.00+50.2% to mean$90.00
# Analysts17
Ownership
Shares Out.134.37M
Float124.50M
Insiders1.73%
Institutions88.06%
Short Interest
Short Ratio5.2d
Short % Float8.15%
Short % Out.8.09%
Shares Short10.74M
Short (prev mo.)14.52M
Technical
SMA 5041.19 (+9.0%)
SMA 20023.30 (+92.7%)
Beta2.26
S&P 52W Chg18.16%
Avg Vol (30d)2.07M
Avg Vol (10d)2.79M
Technical Indicators
RSI (14)55.1
MACD1.0552
MACD Signal1.2261
MACD Hist.-0.1709
BB Upper46.77 USD
BB Middle43.65 USD
BB Lower40.53 USD
BB Width14.29%
ATR (14)2.901 USD
Vol Ratio (20d)0.63x